 |
|
||
|
 |
||||||||||
 |
||||||||||
 |
||||||||||
|
||||||||||
 |
||||||||||
|
||||||||||
 |
||||||||||
|
||||||||||
|
 iPad compatible version can be now be downloaded |
 |
 |
| SCImago Journal & Country Rank |
 |
 |
| The African Journal Archive is a retrospective digitisation project of full-text journal articles published in Africa. Older CVJA articles can be viewed here. |
|
ONLINE MEDIA |
|
SHIFTING the burden of heart failure Ivabradine, the pure heart rate-lowering drug, shown to reduce morbidity and mortality in heart failure. The results of the SHIfT study, announced this week at the European Society of Cardiology (ESC) 2010 congress in Stockholm, are likely to change the clinical treatment of chronic heart failure as they provide the first positive results for many years in this difficult field of treatment. The great interest in the outcome of this study was evident from the large number of delegates attending this hot-line session on the first day of the congress. Download this e-Publication report in PDF |
© 2011 All Rights Reserved
Disclaimer